Welcome Customer !

Membership

Help

Ilebo Biotechnology (Shanghai) Co., Ltd
Custom manufacturer

Main Products:

cep-online>Products

Ilebo Biotechnology (Shanghai) Co., Ltd

  • E-mail

    yilaibo@shyilaibo.com

  • Phone

    15221734409

  • Address

    B650, Block B, No. 180 Changjiang South Road, Baoshan District, Shanghai

Contact Now

Gene editing positive cell screening

NegotiableUpdate on 03/04
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin
Overview
Gene editing positive cell screening refers to the identification and isolation of cells that have successfully undergone target gene modification through specific methods after gene editing experiments (such as CRISPR/Cas9). Common screening methods include antibiotic screening (such as using resistance gene markers), fluorescent protein marker screening, PCR or sequencing validation, etc. This process is crucial for obtaining homozygous or heterozygous mutant cell lines, studying gene function, or constructing disease models.
Product Details

Gene editing positive cell screeningTechnical Strategy and Optimization Process

Positive cell screening is the core process of gene editing, and its efficiency directly affects the experimental cycle and success rate.


1、 Screening Objectives and Challenges

  1. core objective

    • Isolation of successfully edited cells from mixed cell populations (such as gene knockout/KO, knock in/KI).

    • Exclude interference from wild-type cells (high proportion of unedited cells can easily lead to false negatives).

  2. key challenges

    • cell damageLong term screening leads to cell aging (decreased proliferation ability of pig fibroblasts after passage).

    • False positive riskPartial editing did not completely destroy gene function (such as frameshift mutations not causing loss of function).

    • Flow bottleneckTraditional monoclonal culture requires more than 22 days and the positivity rate is less than 20%.


2、 Mainstream screening techniques and operational processes

(1) Enrichment technology based on reporting system

Using repair mechanisms to trigger fluorescence/resistance marker expression, achieving visualization and rapid sorting:

Repair mechanism Report system design screening method advantage case
NUMBER Targeted destruction of fluorescent protein terminators → restoration of expression FACS sorting GFP ⁺ cells Intuitive and efficient, suitable for KO CRISPR-DIY Vector
HDR Homologous recombination insertion of resistance genes (such as Puro ᵣ) Antibiotic stress screening Suitable for KI, low cost Biyun Tian CRISPR plasmid
SSA Fracture induced single chain annealing repair → fluorescent protein reconstruction flow cytometry High sensitivity, low off target rate Multiple gene editing validation

operating procedure(Taking NHEJ-GFP system as an example):

  1. Build withGFP-TAA terminatorThe editing vector (sgRNA targeting TAA region).

  2. After transfection of cells, NHEJ repairs and destroys the terminator → GFP expression.

  3. Use after 72 hoursFlow cytometry (such as iQue) ®) Sorting GFP ⁺ cells.

(2) Rapid identification method for trace cells

Breakthrough planOnly 50 cells are needed to complete genotype identification, shortening the cycle by more than 15 days.

key parameters

  • Cell quantity≥ 50 (insufficient detection rate in the 20 cell group, P<0.01).

  • Enzyme sensitivityT7E1 can detect editing efficiency of ≥ 5%.

  • Verification stepsSanger sequencing confirms the type of mutation (such as insertion/deletion).

(3) Enzyme digestion and sequencing validation technology
method principle Applicable scenarios limitation
T7E1 enzyme digestion Mismatch cutting generates heterologous double chains Initial screening (low-cost) Low sensitivity (≥ 5% editing rate)
Sanger sequencing Directly read sequence variations Monoclonal validation Low flux
high-throughput sequencing Deep coverage of target site mutations Multi gene/off target analysis 成本高

Operation optimization

  • Mixed clone pre screeningFA-PCR detects the population editing rate, and when it exceeds 30%, single clones are sorted.

  • Dual verification strategyT7E1 initial screening positive clones → Sanger sequencing confirmation (to avoid false positives).


3、 Technology selection and scene adaptation

(1) Select by cell type
cell type Recommended methods reason
primary cells Microcellular identification method Avoid aging caused by long-term cultivation (pig fibroblasts)
Tumor cell line Antibiotic screening+FACS Rapid proliferation and stable drug resistance
iPSCs HDR reporting system+monoclonal sequencing Maintaining pluripotency requires high-precision editing
(2) Select by editing type
Edit Type Screening techniques key metrics
Gene knockout (KO) NHEJ-GFP reporting system GFP ⁺ cell proportion (flow cytometry quantification)
Gene Knockin (KI) Antibiotic screening+PCR validation Resistance survival rate+flanking sequence amplification
Point mutation (PM) T7E1+Deep Sequencing Mutation frequency>90%

Gene editing positive cell screening